VERAXA Biotech and Voyager Acquisition Corp. Announce Business Combination to Advance Next-Generation Cancer Therapies
23/4 07:10
VERAXA Biotech and Voyager Acquisition Corp. announced a business combination to develop next-generation cancer therapies, targeting a $1.3 billion valuation....